Calidi Biotherapeutics (Calidi Biotherapeutics) Additional Paid-In Capital : $92.21 Mil(As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Calidi Biotherapeutics Additional Paid-In Capital?

Calidi Biotherapeutics's quarterly additional paid-in capital increased from Sep. 2023 ($90.25 Mil) to Dec. 2023 ($91.38 Mil) and increased from Dec. 2023 ($91.38 Mil) to Mar. 2024 ($92.21 Mil).

Calidi Biotherapeutics's annual additional paid-in capital increased from Dec. 2021 ($13.32 Mil) to Dec. 2022 ($19.93 Mil) and increased from Dec. 2022 ($19.93 Mil) to Dec. 2023 ($91.38 Mil).

Calidi Biotherapeutics Additional Paid-In Capital Historical Data

The historical data trend for Calidi Biotherapeutics's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Calidi Biotherapeutics Additional Paid-In Capital Chart

Calidi Biotherapeutics Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Additional Paid-In Capital

11.95

13.32

19.93

91.38

Calidi Biotherapeutics Quarterly Data
	Dec20	Sep21	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Additional Paid-In Capital	Get a 7-Day Free Trial					-	25.63	90.25	91.38	92.21

Calidi Biotherapeutics Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Calidi Biotherapeutics Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Calidi Biotherapeutics's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Calidi Biotherapeutics (Calidi Biotherapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Calidi Biotherapeutics Inc (AMEX:CLDI) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

11011 North Torrey Pines Road, Suite 200, La Jolla, CA, USA, 92037

Website

https://www.calidibio.com

Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.

Calidi Biotherapeutics (Calidi Biotherapeutics) Headlines

From GuruFocus

Calidi Biotherapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Mone(TM) Show on Bloomberg TV

By ACCESSWIRE • 05-17-2024